• Profile
Close

Elevated urinary orosomucoid excretion as a novel biomarker in Crohn’s disease

European Journal of Clinical Investigation Dec 18, 2018

Szirmay B, et al. - Researchers analyzed 86 patients with Crohn’s disease (CD) and 68 healthy individuals (control group) and categorized them according to their clinical scores (Harvey-Bradshaw Index [HBI] or Pediatric Crohn's Disease Activity Index [PCDAI]) to examine urinary concentrations of orosomucoid (u-ORM) in association with inflammatory activity of CD and compare it with clinical criteria and traditional laboratory parameters. They determined urinary u-ORM by automated immune turbidimetric assay, and values were referred to urinary creatinine (u-ORM/u-CREAT, mg/mmol). They and observed U-ORM/u-CREAT values seven times greater in children with active CD and two times greater in adults vs those with inactive disease. They noted an association of U-ORM/u-CREAT with conventional inflammatory markers (hs-CRP, serum ORM) and activity indices (HBI, P=0.018; PCDAI).

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay